CancerIQ
PrivateLast Round
Seed Round
May 26, 2026
Total Funding Raised
$18.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CancerIQ is a health technology company that provides a precision health platform for healthcare providers to identify, manage, and personalize care for patients at high risk for cancer.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Precision Medicine, Healthcare Analytics, Patient Engagement, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CancerIQ Comparables
Compare CancerIQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Azra AI | 81% | |
| Lunit | 81% | |
| PenRad Technologies | 77% | |
CancerIQ Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 26, 2026 | ||||
| Debt | Aug 21, 2024 | ||||
| Series B | Mar 3, 2022 | ||||
| Series A | Aug 13, 2020 |
Key People
Founding team and executive leadership
CancerIQ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lightbank | Series A |
| HealthX Ventures | Series B, Series A |
| Decathlon Capital Partners | Debt |
| McKesson Ventures | Series B |
| OSF Ventures | Series B |
| McKesson Ventures | Series B |
| The Impact Engine | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 106% MoM, reaching 26K.
- May 26, 2026
$4.3M raised in Seed Round.
CancerIQ Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CancerIQ's valuation, stock price, and market status.